Modifiable lifestyle factors in patients with myeloproliferative neoplasms in the California teachers study

E Elias Gennaoui (1California University of Science and Medicine, Colton, United States) J Jeffrey Li (2City of Hope, Duarte, United States) A Ashley Larsen H Haley Marcus (4University of California, San Diego, United States) J Jenna Marcus (4University of California, San Diego, United States) E Emma Spielfogel (5City of Hope, Department of Computational and Quantitative Medicine, Duarte, United States) J James Lacey (5City of Hope, Department of Computational and Quantitative Medicine, Duarte, United States) K Krisstina Gowin (3City of Hope, Cherng Family Center for Integrative Oncology, Irvine, United States)

Abstract

Abstract Introduction: Myeloproliferative Neoplasms (MPNs) are a rare set of hematologic malignancies associated with thrombotic complications. While interventions such as therapeutic phlebotomy, aspirin, and cytoreductive therapy are helpful thrombotic risk reduction strategies, modification of cardiovascular risk factors is also recommended. We conducted a descriptive analysis on modifiable lifestyle behaviors of patients with MPNs in the California Teachers Study (CTS) cohort. Methods: We conducted a descriptive analysis using data from the CTS, a prospective cohort of over 130,000 adult women who enrolled in 1995 and have been followed continuously, via self-reported surveys and data linkages since. We identified participants diagnosed with MPNs (n=162), including polycythemia vera, essential thrombocytopenia, and primary myelofibrosis. Lifestyle factors were extracted from baseline questionnaires, including smoking status, alcohol intake, physical activity, and dietary patterns. We summarized baseline characteristics and lifestyle distributions of the MPN cohort. Results: The MPN cohort comprised a total of 162 participants, all of which are female with a mean age of 58.2 years old. Mean pack years was 15.4, 51.5% were never smokers, 45.9% were former smokers, and 2.4% were current smokers. Mean BMI was 25.08 with 60.5% were classified as underweight or normal, while 39.4% were classified as overweight or obese. Mean recent alcohol use was 7.1 g/day, with 40.3% of participants with no alcohol use, 51.2% drinking less than 20 g/day (approximately 1.25 drinks/day), and 8.3% drinking more than 20 g/day. Participants had a mean of 3.8 hours of moderate/strenuous exercise per week. Conclusion: The California Teacher Study MPN cohort offers longitudinal insight into the modifiable lifestyle behaviors of female patients afflicted with MPNs in California. More than a third of the cohort is overweight or obese (39.4%), suggesting weight management programs may be particularly important in this population. Alcohol consumption is present in 59.5% of the participants, which may contribute to inflammatory and thrombotic complications in MPN, suggesting that cessation may be an important modifiable risk factor in this cohort. Tobacco use was low with only 2.4% being current smokers. Physical activity shows a low-moderate engagement in exercise. Future studies incorporating survival data and additional modifiable lifestyle factors are needed to better understand the impact of lifestyle factors on survival.

Article Details

Journal Blood
Volume / Issue Vol. 146, Issue Supplement 1
Published November 03, 2025
Pages 7340-7340
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (8)

E

Elias Gennaoui

1California University of Science and Medicine, Colton, United States

J

Jeffrey Li

2City of Hope, Duarte, United States

A

Ashley Larsen

H

Haley Marcus

4University of California, San Diego, United States

J

Jenna Marcus

4University of California, San Diego, United States

E

Emma Spielfogel

5City of Hope, Department of Computational and Quantitative Medicine, Duarte, United States

J

James Lacey

5City of Hope, Department of Computational and Quantitative Medicine, Duarte, United States

K

Krisstina Gowin

3City of Hope, Cherng Family Center for Integrative Oncology, Irvine, United States